BioCentury | Jan 14, 2021
Deals

Jan. 13 Quick Takes: Takeda, KSQ enter immunotherapy deal; plus Taysha, Cardea, Esperion-Serometrix, Paion-La Jolla and more

...Amgen team up on autoimmunityAmgen Inc. (NASDAQ:AMGN) will gain exclusive rights to autoimmune programs from Evoq Therapeutics LLC...
BioCentury | Mar 16, 2017
Product R&D

Neo wave

...neoantigens, in combination with Keytruda pembrolizumab from Merck & Co. Inc. Cancer Preclinical Unknown N/A EVOQ Therapeutics LLC...
Items per page:
1 - 2 of 2
BioCentury | Jan 14, 2021
Deals

Jan. 13 Quick Takes: Takeda, KSQ enter immunotherapy deal; plus Taysha, Cardea, Esperion-Serometrix, Paion-La Jolla and more

...Amgen team up on autoimmunityAmgen Inc. (NASDAQ:AMGN) will gain exclusive rights to autoimmune programs from Evoq Therapeutics LLC...
BioCentury | Mar 16, 2017
Product R&D

Neo wave

...neoantigens, in combination with Keytruda pembrolizumab from Merck & Co. Inc. Cancer Preclinical Unknown N/A EVOQ Therapeutics LLC...
Items per page:
1 - 2 of 2